🇺🇸 FDA
Patent

US 6355610

Inhibitors of formation of protease resistant prion protein

expired A61KA61K38/00

Quick answer

US patent 6355610 (Inhibitors of formation of protease resistant prion protein) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K38/00